ATE145137T1 - Synthetischer poly-ig-rezeptor, rezeptor- antikörper-komplexe, herstellung und anwendung - Google Patents

Synthetischer poly-ig-rezeptor, rezeptor- antikörper-komplexe, herstellung und anwendung

Info

Publication number
ATE145137T1
ATE145137T1 AT91909070T AT91909070T ATE145137T1 AT E145137 T1 ATE145137 T1 AT E145137T1 AT 91909070 T AT91909070 T AT 91909070T AT 91909070 T AT91909070 T AT 91909070T AT E145137 T1 ATE145137 T1 AT E145137T1
Authority
AT
Austria
Prior art keywords
receptor
poly
preparation
disclosed
methods
Prior art date
Application number
AT91909070T
Other languages
English (en)
Inventor
Jean-Pierre Kraehenbuhl
Richard A Weltzin
Marian R Neutra
Original Assignee
Harvard College
Suisse Rech Experiment
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College, Suisse Rech Experiment filed Critical Harvard College
Application granted granted Critical
Publication of ATE145137T1 publication Critical patent/ATE145137T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT91909070T 1990-04-16 1991-04-16 Synthetischer poly-ig-rezeptor, rezeptor- antikörper-komplexe, herstellung und anwendung ATE145137T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51016190A 1990-04-16 1990-04-16

Publications (1)

Publication Number Publication Date
ATE145137T1 true ATE145137T1 (de) 1996-11-15

Family

ID=24029610

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91909070T ATE145137T1 (de) 1990-04-16 1991-04-16 Synthetischer poly-ig-rezeptor, rezeptor- antikörper-komplexe, herstellung und anwendung

Country Status (21)

Country Link
EP (1) EP0480014B1 (de)
JP (1) JPH05501118A (de)
KR (1) KR920702625A (de)
CN (1) CN1057785A (de)
AT (1) ATE145137T1 (de)
AU (2) AU7792691A (de)
BG (1) BG95634A (de)
BR (1) BR9105717A (de)
CA (1) CA2059289A1 (de)
DE (1) DE69123121T2 (de)
DK (1) DK0480014T3 (de)
ES (1) ES2097207T3 (de)
FI (1) FI915881A0 (de)
GR (1) GR3022512T3 (de)
HU (1) HUT63059A (de)
NO (1) NO914946L (de)
OA (1) OA09647A (de)
RO (1) RO109703B1 (de)
RU (1) RU2124050C1 (de)
WO (1) WO1991016061A1 (de)
ZA (1) ZA912837B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5443832A (en) * 1990-04-16 1995-08-22 Institut Swisse De Recherches Experimentales Sur Le Cancer Hydroxyapatite-antigen conjugates and methods for generating a poly-Ig immune response
EP0675734A4 (de) * 1992-12-21 1997-05-07 Tanox Biosystems Inc ALLERGENSPEZIFISCHE, MONOKLONALE IgA-ANTIKÖRPER UND ÄHNLICHE PRODUKTE FÜR DIE ALLERGIEBEHANDLUNG.
US6046037A (en) * 1994-12-30 2000-04-04 Hiatt; Andrew C. Method for producing immunoglobulins containing protection proteins in plants and their use
US6808709B1 (en) 1994-12-30 2004-10-26 The Regents Of The University Of California Immunoglobulins containing protection proteins and their use
WO1996021012A1 (en) 1994-12-30 1996-07-11 Planet Biotechnology, Inc. Methods for producing immunoglobulins containing protection proteins in plants and their use
EP0839915A1 (de) * 1996-11-01 1998-05-06 Institut Suisse De Recherches Experimentales Sur Le Cancer Isrec Sekretorisches Immunglobulin A als schleimhautspezifisches Impfstoffverabreichungssystem
ATE442386T1 (de) 2000-04-28 2009-09-15 Planet Biotechnology Inc Immunoadhesin zur impfung gegen rhinovirus
AU2001272908A1 (en) 2000-05-10 2001-11-20 David A. Sirbasku Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers
RU2186390C1 (ru) * 2001-01-26 2002-07-27 Научно-исследовательский институт эпидемиологии и микробиологии им. Н.Ф. Гамалеи РАМН Способ выделения пневмоцист
GB201101429D0 (en) * 2011-01-27 2011-03-16 Biocompatibles Uk Ltd Drug delivery system
CN104903727B (zh) * 2012-11-08 2019-10-22 马克法兰伯尼特医学研究与公共健康协会有限公司 诊断、预后、治疗和筛选方案
RU2605321C1 (ru) * 2015-07-16 2016-12-20 Федеральное государственное бюджетное учреждение науки Институт химической биологии и фундаментальной медицины Сибирского отделения Российской академии наук (ИХБФМ СО РАН) Фракция днк-гидролизующих секреторных иммуноглобулинов класса а, обладающая избирательной апоптотической активностью по отношению к раковым клеткам человека

Also Published As

Publication number Publication date
JPH05501118A (ja) 1993-03-04
AU687443B2 (en) 1998-02-26
DE69123121T2 (de) 1997-04-03
BG95634A (bg) 1993-12-24
DE69123121D1 (de) 1996-12-19
AU7792691A (en) 1991-11-11
EP0480014A1 (de) 1992-04-15
HUT63059A (en) 1993-07-28
BR9105717A (pt) 1992-07-21
NO914946L (no) 1992-02-12
DK0480014T3 (da) 1997-02-17
ES2097207T3 (es) 1997-04-01
GR3022512T3 (en) 1997-05-31
NO914946D0 (no) 1991-12-13
ZA912837B (en) 1992-03-25
OA09647A (en) 1993-04-30
FI915881A7 (fi) 1991-12-13
AU7771594A (en) 1995-04-06
CA2059289A1 (en) 1991-10-17
WO1991016061A1 (en) 1991-10-31
FI915881A0 (fi) 1991-12-13
RO109703B1 (ro) 1995-05-30
EP0480014A4 (en) 1992-10-14
CN1057785A (zh) 1992-01-15
KR920702625A (ko) 1992-10-06
HU9200136D0 (en) 1992-04-28
RU2124050C1 (ru) 1998-12-27
EP0480014B1 (de) 1996-11-13

Similar Documents

Publication Publication Date Title
DE69023900T4 (de) Gentechnologisch veränderte immunglobuline.
DE69123121D1 (de) Synthetischer poly-ig-rezeptor, rezeptor-antikörper-komplexe, herstellung und anwendung
Lanzavecchia et al. The use of hybrid hybridomas to target human cytotoxic T lymphocytes
EP0571613A4 (en) Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
DE3750342D1 (de) Menschliches gamma-interferon-spezifisches Rezeptorprotein, Antikörper gegen dieses Protein, Verfahren zur Herstellung dieses Proteins und dieses Antikörpers und dieses Protein und diesen Antikörper enthaltende Zusammensetzungen.
DE60334364D1 (de) Behandlungsverfahren unter verwendung von anti-cd22-antikörpern
KR920701465A (ko) Cd4 특이적 재조합 항체
LU91448I2 (fr) "panitumumab"
DE69943359D1 (de) Tumorassoziierte Antigenderivate der Mage-Familie, zur Herstellung von Fusionsproteinen mit T-Helper Epitope und Zusammensetzungen zur Impfung
CA2290485A1 (en) Method for the production of non-immunogenic proteins
DE60129278T2 (de) Gegen das SEMP1-Protein gerichtete Antikörper, Verfahren zu deren Herstellung, und deren Anwendungen
DE69133622D1 (de) Transferrin bindende Proteine aus Neisseria-Gonorrhoeae und Neisseria-Meningitidis. Ihre Verwendung in einem Impfstoff
DK1129186T3 (da) Et faktor VIII-polypeptid med faktor VIII:C-aktivitet
ES2102347T3 (es) Metodos y composiciones para la utilizacion de polipeptidos env y anticuerpos anti-env de hiv.
DE3854300T2 (de) Lymphocyteninhibierung durch hla-peptide.
DK0996726T3 (da) T-celle-membranprotein (TIRC7), peptider og antistoffer afledt deraf og anvendelse deraf
DE10299038I1 (de) Plaettchen-Spezifisches Chimaerisches Immunglobulin
DK0493446T3 (da) Behandling af autoimmunsygdom.
ATE233811T1 (de) Blutplaettchen-gpiiia p1a1 und -p1a2-epitope, ihre herstellung und verwendung
Forsberg et al. Purification and characterization of integrin α9β1
Maruoka et al. A novel monoclonal antibody permitting recognition of NKT cells in various mouse strains
KR890016165A (ko) 수도모나스 아에루기노사(Pseudomonas aeruginosa)에 대한 모노클로날 항체, 이의 제조방법 및 용도
Wilkinson et al. Modulation of peptide specific T cell responses by non-native flanking regions
DE69020914D1 (de) Monoklonale Antikörper von Ratten gegen menschliche Antigene und Verfahren zu deren Herstellung.
Iwata et al. Association of glycosylation-inhibiting factor with plasma membranes of T suppressor cell hybridomas.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee